Vermont et al identified levels of serum chemokines that are predictive of poor survival in pediatric patients with meningococcal sepsis. These can help identify patients who may require more aggressive management. The authors are Erasmus MC-Sophia Children's Hospital in Rotterdam and the Netherlands Vaccine Institute.